Multiple Sclerosis

Latest News

Most Real-World Studies Report Positive Outcomes of Rituximab Use in Multiple Sclerosis
Most Real-World Studies Report Positive Outcomes of Rituximab Use in Multiple Sclerosis

May 8th 2024

Although several clinical trials have confirmed the safety and efficacy of rituximab in oncology and autoimmune disease, and even as off-label use in MS, real-world evidence is still necessary to help guide clinicians and managed care professionals in their treatment and coverage decision-making.

Diabetes Weight Loss Drugs Could be Linked to Reduced Risk of MS, Study Finds
Diabetes Weight Loss Drugs Could be Linked to Reduced Risk of MS, Study Finds

April 12th 2024

Specialty Pharmacist Interventions Result in More Than $150,000 in Cost Avoidance For MS Patients
Specialty Pharmacist Interventions Result in More Than $150,000 in Cost Avoidance For MS Patients

April 4th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.